Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Treatment with Erythropoietin and G-CSF Improves Survival in MDS Patients with Low Transfusion Need.

Martin Jädersten, MD, Luca Malcovati, MD, Ingunn Dybedal, MD, Matteo Giovanni Della Porta, MD, Rosangela Invernizzi, MD, Scott M. Montgomery, PhD, Cristiana Pascutto, Anna Porwit-MacDonald, MD, Mario Cazzola, MD, Eva Hellström-Lindberg, MD, PhD

Blood (2006) 108 (11): 521.

https://doi.org/10.1182/blood.V108.11.521.521

Published: 2006

Journal Articles

Leukotrienes Stimulate the Release of Cytokines and Proliferation of Hodgkin Reed-Sternberg Cells.

Jan Sjoberg, MD, PhD, Frida Schain, Ylva Tryselius, PhD, Linda Backman, Maria Malec, PhD, Anna Porwit-MacDonald, MD, PhD, Magnus Bjorkholm, MD, PhD, Hans-Erik Claesson, MD, PhD

Blood (2006) 108 (11): 2263.

https://doi.org/10.1182/blood.V108.11.2263.2263

Published: 2006

Journal Articles

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

Martin Jädersten, Scott M. Montgomery, Ingunn Dybedal, Anna Porwit-MacDonald, Eva Hellström-Lindberg

Blood (2005) 106 (3): 803–811.

https://doi.org/10.1182/blood-2004-10-3872

Published: 2005

Journal Articles

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Erik Björck, Sara Ek, Ola Landgren, Mats Jerkeman, Mats Ehinger, Magnus Björkholm, Carl A. K. Borrebaeck, Anna Porwit-MacDonald, Magnus Nordenskjöld

Blood (2005) 105 (7): 2908–2915.

https://doi.org/10.1182/blood-2004-07-2721

Published: 2005

Journal Articles

Patterns of Expression of CD15, CD33, CD34 and HLA-DR Predict Prognosis in Patients with AML.

Asa Rangert-Derolf, MD, Elisabet Bjorklund, PhD, Joanna Mazur, PhD, Magnus Bjorkholm, Anna Porwit-MacDonald

Blood (2004) 104 (11): 3007.

https://doi.org/10.1182/blood.V104.11.3007.3007

Published: 2004

Journal Articles

The WHO classification of MDS does make a difference

Robert B. Howe, Anna Porwit-MacDonald, Robert Wanat, Ramin Tehranchi, Eva Hellström-Lindberg

Blood (2004) 103 (9): 3265–3270.

https://doi.org/10.1182/blood-2003-06-2124

Published: 2004

Journal Articles

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Blood (2003) 101 (10): 4047–4054.

https://doi.org/10.1182/blood-2002-11-3479

Published: 2003

NARROW

Treatment with Erythropoietin and G-CSF Improves Survival in MDS Patients with Low Transfusion Need.

Leukotrienes Stimulate the Release of Cytokines and Proliferation of Hodgkin Reed-Sternberg Cells.

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Patterns of Expression of CD15, CD33, CD34 and HLA-DR Predict Prognosis in Patients with AML.

The WHO classification of MDS does make a difference

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Treatment with Erythropoietin and G-CSF Improves Survival in MDS Patients with Low Transfusion Need.

Leukotrienes Stimulate the Release of Cytokines and Proliferation of Hodgkin Reed-Sternberg Cells.

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Patterns of Expression of CD15, CD33, CD34 and HLA-DR Predict Prognosis in Patients with AML.

The WHO classification of MDS does make a difference

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only